STACY D'ANDRE, M.D.
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1629053939
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 300 | 46,167 | $4,232,289 | $1,385,862 | $1,101,114 |
| 2023 | 348 | 51,420 | $3,900,021 | $1,233,940 | $982,389 |
| 2022 | 304 | 43,750 | $3,322,196 | $1,113,578 | $887,525 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 4,760 | $29 | $23 |
| J9271 | Injection, pembrolizumab, 1 mg | 4,700 | $51 | $41 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,782 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 3,450 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 2,850 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 688 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 630 | $1 | $1 |
| J9041 | Injection, bortezomib, 0.1 mg | 580 | $2 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 308 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 224 | $16 | $13 |
| J9190 | Injection, fluorouracil, 500 mg | 162 | $3 | $2 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 157 | $131 | $97 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 69361 | MN |
| Hematology & Oncology Physician | 207RH0003X | A85051 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1801877501
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.